The Excessive Daytime Sleepiness Market to Grow Positively at a Significant CAGR, estimates DelveInsight

United States, Nevada, Las Vegas, DelveInsight’s “Excessive Daytime Sleepiness Market Insight, Epidemiology and Market Forecast – 2032” report provides current treatment practices, emerging drugs, Excessive Daytime Sleepiness market share of the individual therapies, current and forecasted Excessive Daytime Sleepiness market size from 2019 to 2032 segmented by seven major markets. The report also offers current Excessive Daytime Sleepiness therapy algorithms, market drivers, market barriers, and unmet medical needs to curate the best of the opportunities and assesses the underlying potential of the Excessive Daytime Sleepiness market.

Excessive Daytime Sleepiness Overview
Excessive Daytime Sleepiness is characterized by a difficulty to stay awake and alert during the major waking episodes of the day, with sleep occurring unintentionally or at inappropriate times of the wake period. Excessive Daytime Sleepiness is often associated with a wide range of illnesses, including metabolic, cardiovascular, neurological, and psychiatric diseases with voluntary behaviors reflecting poor sleep and sleep debt, leading to disability and increased risk of mortality. Excessive Daytime Sleepiness is also commonly associated with social and economic consequences, thus constituting a significant public health problem.

Excessive Daytime Sleepiness Epidemiological Insights
Assessments as per DelveInsight analysis showed that the US accounted for majority of cases in the 7MM with approximately 3,736,749 diagnosed prevalent cases in 2021.

Excessive Daytime Sleepiness Treatment Market
The evaluation and management of Excessive Daytime Sleepiness are based on the identification and treatment of underlying conditions (particularly Narcolepsy, Parkinson’s disease, Obstructive sleep apnea (OSA), Idiopathic hypersomnia (IH), and Bipolar Disorder, etc.). For all the indications, the mainstay of treatment is supportive care and approved therapies to alleviate the symptoms. Supportive therapies include armodafinil (R-enantiomer of modafinil), amphetamine, methamphetamine, dextroamphetamine, and methylphenidate, etc.
Sleepiness is usually treated using amphetamine-like CNS stimulants (i.e., methylphenidate or modafinil and its R-enantiomer, armodafinil), which are wake-promoting compounds unrelated to amphetamines. More recently, the American Academy of Sleep Medicine (AASM) recommended the use of sodium oxybate, a short-lasting sedative of unknown mechanisms, as the first-line treatment of Excessive Daytime Sleepiness and cataplexy. The most commonly used amphetamine-like compounds are methylphenidate, methamphetamine, D-amphetamine (all schedule II compounds), and mazindol (a schedule IV compound). The clinical use of stimulants in narcolepsy often has been the subject of standards of practice published by AASM.

Promising Therapies in the Excessive Daytime Sleepiness Pipeline
• Wakix/ Ozawade (Pitolisant)
• Sunosi (Solriamfetol)
• FT218 (Sodium Oxybate)
• AXS-12 (Reboxetine)
• And others

Discover more about Excessive Daytime Sleepiness therapies in the pipeline @ Excessive Daytime Sleepiness Drugs

Leading Companies Working in the Excessive Daytime Sleepiness Market
• Bioprojet Pharma
• Harmony Biosciences
• Jazz Pharmaceuticals
• Avadel Pharmaceutical
• Axsome Therapeutic
• And others

To understand key companies related to the Excessive Daytime Sleepiness Market, get a snapshot of the Excessive Daytime Sleepiness Regulatory and Patent Analysis.
https://www.delveinsight.com/sample-request/excessive-daytime-sleepiness-eds-market?utm_source=digitaljournal&utm_medium=pressrelease&utm_campaign=kpr

Scope of the Excessive Daytime Sleepiness Market Report
Study Period: 2019–2032
Coverage: 7MM [The United States, EU5 (Germany, France, Italy, Spain, and the United Kingdom), Japan]
Key Excessive Daytime Sleepiness Companies: Bioprojet Pharma, Harmony Biosciences, Jazz Pharmaceuticals, Avadel Pharmaceutical, Axsome Therapeutic, and others
Key Excessive Daytime Sleepiness Pipeline Therapies: Wakix/ Ozawade (Pitolisant), Sunosi (Solriamfetol), FT218 (Sodium Oxybate), AXS-12 (Reboxetine), and others
Therapeutic Assessment: Excessive Daytime Sleepiness current marketed and emerging therapies
Excessive Daytime Sleepiness Market Dynamics: Excessive Daytime Sleepiness market drivers and barriers
Competitive Intelligence Analysis: SWOT analysis, PESTLE analysis, Porter’s five forces, BCG Matrix, Market entry strategies
Unmet Needs, KOL’s views, Analyst’s views, Excessive Daytime Sleepiness Market Access and Reimbursement

Table of Contents
1. Excessive Daytime Sleepiness Market Key Insights
2. Excessive Daytime Sleepiness Market Report Introduction
3. Excessive Daytime Sleepiness Market Overview at a Glance
4. Excessive Daytime Sleepiness Market Executive Summary
5. Disease Background and Overview
6. Excessive Daytime Sleepiness Treatment and Management
7. Excessive Daytime Sleepiness Epidemiology and Patient Population
8. Patient Journey
9. Excessive Daytime Sleepiness Emerging Drugs
10. 7MM Excessive Daytime Sleepiness Market Analysis
11. Excessive Daytime Sleepiness Market Outlook
12. Potential of Current and Emerging Therapies
13. KOL Views
14. Excessive Daytime Sleepiness Market Drivers
15. Excessive Daytime Sleepiness Market Barriers
16. Unmet Needs
17. SWOT Analysis
18. Appendix
19. DelveInsight Capabilities
20. Disclaimer
21. About DelveInsight

Trending Reports by DelveInsight:
• Asthma Diagnostic Devices Market
• Chronic Obstructive Pulmonary Disease Treatment Devices Market
• Airway Management Devices Market
• Cough Assist Devices Market
• Pulse Oximeters Market
• Hemodialysis Catheter Devices Market
• Chronic Spontaneous Urticaria Market
• Gender Dysphoria Market
• Germany Healthcare Outlook
• Biopsy Devices Pipeline Insight
• Bacterial Conjunctivitis Market
• Infliximab Biosimilar Insight
• Eosinophilic Asthma Market
• Cushing Syndrome Market
• Functional Dyspepsia Market
• Peripherally Inserted Central Catheters (PICC) Devices Market

About DelveInsight
DelveInsight is a leading Business Consultant and Market Research firm focused exclusively on life sciences. It supports pharma companies by providing comprehensive end-to-end solutions to improve their performance. Get hassle-free access to all the healthcare and pharma market research reports through our subscription-based platform PharmDelve.

Contact Us
Kritika Rehani
info@delveinsight.com
+1(919)321-6187